# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
djusted EBITDA of greater than $150 million, updated from prior guidance of Adjusted EBITDA between $146 million and $150 million
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate...
Deutsche Bank analyst Pito Chickering maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Buy and raises the price targe...
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported adjusted quarterly losses of $(0.02) per share which met the analyst consensus ...
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
JP Morgan analyst Lisa Gill downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underweight.